Excited to welcome Dr. Ryan Larsen to Kearney Urology Center! It’s a great time for our practice as we continue to grow and expand our ability to provide high-quality urologic care to our patients and community. Welcome to the team, Dr. Larsen — we’re glad to have you with us!
Prostate cancer treatment decisions are rarely straightforward. Treatment or surveillance? Hormones or no hormones? Dr. @HafronJason explains why @arteraAI is helping bring greater precision to these decisions. https://t.co/HHGyp95IKa
Where does Optilume BPH fit in the modern BPH care pathway?
Dr. Garrett Pohlman @gpohlmanmd explores The Chemical Overlay, adding another option to an increasingly personalized approach to BPH
More tools. Better matching. Treatment built around patient goals. 🔧
#IFRUE2026 #BPH #MensHealth
When the prostate gets BIG, what makes it into your playbook? 👀
Drs. Alexander Glaser, @apglaser Garrett Pohlman @gpohlmanmd, Fernando Kim, Joel Funk @jfunkmd & David Hadley face off in the Big Gland Shootout: Larger Footprint, Maximum Success.🥊
Different techniques. Different tradeoffs. One very large problem to solve.
#IFRUE2026 #BPH #Endourology
An Episode 114 highlight - Dr. @HafronJason shares how he uses the @arteraAI Prostate Test to guide his treatment decisions and help avoid over-treatment and under-treatment. https://t.co/EsjFfD3PrK
Today, we are delighted to welcome @HafronJason to discuss the @arteraAI Prostate Test and explain how it helps clinicians and patients determine the optimal personalized prostate cancer treatment plan. https://t.co/u2fNH2XOSd
Where is the future of BPH care headed?
🎙️Dr. Garrett Pohlman @gpohlmanmd discusses the rise of office-based, minimally invasive approaches that treat obstructive tissue while recognizing that BPH care is never one-size-fits-all
The future is personalized treatment for each patient’s anatomy, symptoms, and goals↗️
@AustenSlade - Dr. Slade highlights the rapid worldwide growth of HoLEP and explains why he expects the procedure to become increasingly available. https://t.co/f3OzvMMUIG
Possibly the only time a urologist will ask you not to use the restroom.
Many urology evaluations rely on a full bladder for UA, uroflow, and post-void residual testing.
Sometimes great healthcare isn't about new technology—it's about clear communication.
Episode 112 highlight - #Urologist Jeffrey Wolters, MD and #RadiationOncologist Coyt Rountree, MD give a multidisciplinary perspective on rectal spacing for radiation therapy in prostate cancer. #BioProtect@BioprotectS
Episode 112 highlights - #Urologist Jeffrey Wolters, MD and #RadiationOncologist Coyt Rountree, MD give a multidisciplinary perspective on rectal spacing for radiation therapy in prostate cancer. #BioProtect@BioprotectS
Honored to join Dr. Drew this evening (4 PM CST / 5 PM EST) on Fox Business Network’s - Dr. Drew’s Health Uncensored to discuss the evolving landscape of #ProstateCancer screening and detection.
@MaleHealthDoc presenting 3 year @LABORIEMEDICAL#TURBO#optilumeBPH outcomes #AUA2026 - never seen before QMAX improvements for #MIST. ZERO sexual/ejacltn impact. Fast recovery. Also learnt from #BPH GURU = “if you don’t have CONFLICT, you don’t have INTEREST”- stay curious! 🧐
“Bring Your Wife to Work Day” at the AUA Annual Meeting in Washington DC.
My wife officially joined our team this year as Research Coordinator. She’s helped lead our first randomized controlled trial + multiple post-market studies and absolutely crushing it. #AUA2026
For the first time on the podcast, we’re featuring both a urologist and a radiation oncologist for a true multidisciplinary perspective on how a biodegradable balloon spacer provides precise, predictable spacing for radiation therapy. https://t.co/ApnVrmH7BW @BioprotectS